七月 2026
- Home
- Pillar Biosciences Inc.
七月 2026的Pillar Biosciences Inc.市场份额分析
Explore the top five reasons to go custom with your NGS panel, outlined in this Pillar Biosciences blog post
Pillar Biosciences Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- pillarbiosci.com
Pillar Biosciences Inc.热门域名的总访问量
了解Pillar Biosciences Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Pillar Biosciences Inc.热门域名的平均访问时长
分析Pillar Biosciences Inc.参与度指标。
过去 3 个月的平均访问时长
子公司明细
Pillar Biosciences Inc.热门域名的平均页面浏览量
了解Pillar Biosciences Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Pillar Biosciences Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻GenomOncology LLC partnered with Pillar Biosciences, Inc. on Feb 1st '25.Similarly, GenomOncology partnered with Pillar Biosciences in February 2025 to pair clinical decision support software with targeted NGS panels for faster, more personalized cancer treatment guidance.
八月 20, 2026阅读更多
新闻Pillar Biosciences, Inc. partnered with Mitsubishi Chemical Medience Corporation on Aug 20th '26.NATICK, Mass. and TOKYO, Aug. 19, 2026 /PRNewswire/ - Pillar Biosciences, Inc. ("Pillar"), LC-SCRUM-Asia and LSI Medience Corporation ("LSI Medience") today announced a collaboration to support genomic screening of blood-based samples from patients with lung cancer as part of the LC-SCRUM-Asia project in Japan.
八月 19, 2026阅读更多
新闻CellCarta Group partnered with Pillar Biosciences Incorporated on Apr 2nd '26.CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials.
四月 7, 2026阅读更多
查看 Pillar Biosciences Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
